热门资讯> 正文
Tilray Medical推出Tilray Medical Italia，进军意大利
2026-01-22 19:42
- Tilray Medical, a division of Tilray Brands (TLRY), announced a strategic update to its medical cannabis operations in Italy with the launch of Tilray Medical Italia, the new name of the entity formerly known as FL Group.
- The move to Tilray Medical Italia underscores the company’s effort to build a unified medical cannabis platform across Europe while strengthening its presence in one of the region’s key regulated markets.
- Tilray Medical Italia is expanding its footprint in Italy through a growing portfolio of medical cannabis products authorized by the Italian Ministry of Health and supported by a partnership with Molteni Farmaceutici.
More on Tilray
- International Cannabis Expansion Gives Tilray Positive 2026 Outlook
- Tilray Brands, Inc. (TLRY) Q2 2026 Earnings Call Transcript
- Wall Street Lunch: Craft Beers Enter 2026 On Choppy Waters
- Tilray anticipates $150M global medical cannabis revenue run rate as international expansion accelerates
- Tilray rises as it achieves record quarterly revenue on cannabis sales growth
推荐文章
风险及免责提示：以上内容仅代表作者的个人立场和观点，不代表华盛的任何立场，华盛亦无法证实上述内容的真实性、准确性和原创性。投资者在做出任何投资决定前，应结合自身情况，考虑投资产品的风险。必要时，请咨询专业投资顾问的意见。华盛不提供任何投资建议，对此亦不做任何承诺和保证。
